The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition
Official Title: Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition at Toulouse and Bordeaux University Hospital
Study ID: NCT03284593
Brief Summary: The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared patients treated with intensive chemotherapy or azacitidine within two centres.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
University Hospital Bordeaux, Bordeaux, , France
University Hospital Toulouse, Toulouse, , France
Name: Christian RECHER, MD
Affiliation: University Hospital, Toulouse
Role: PRINCIPAL_INVESTIGATOR